腎臓結石回収装置の世界市場 - 2025年～2033年

世界の腎臓結石回収装置市場は2023年に26億7,000万米ドルに達し、2033年には43億米ドルに達すると予測され、予測期間2025年から2033年にはCAGR 4.8%で成長する見込みです。

腎結石症は、腎石症とも呼ばれ、腎臓のミネラルや塩分の結晶が関与する一般的な泌尿器疾患です。治療には、ESWL、尿管鏡、PCNL機器、高度画像システムなどの専門医療機器が用いられます。技術の進歩により、患者の転帰を改善し回復時間を短縮する、低侵襲で非常に効果的な機器が開発されています。腎臓結石症の有病率の増加と非侵襲的治療への需要が、この医療機器分野の技術革新を引き続き促進しています。

市場力学：

促進要因と抑制要因

腎結石疾患の有病率の上昇

世界の腎臓結石回収装置市場は、世界人口の10～15％が罹患している腎臓結石症の有病率の増加により成長しています。不健康な食生活、肥満、脱水、座りっぱなしのライフスタイルなどの要因が腎臓結石発症の急増に寄与しています。このため、尿管鏡、砕石器、結石回収バスケットのような効果的で低侵襲なソリューションに対する需要が生まれています。早期診断と高度な治療オプションに対する意識の高まりは、より多くの患者が医療介入を求めることを促し、市場の成長をさらに後押ししています。患者中心の革新的な結石回収装置に対する需要は飛躍的に伸びると予想され、メーカーやヘルスケアプロバイダーに大きなビジネスチャンスをもたらしています。

例えば、腎臓結石症は米国では毎年500人に1人が罹患しており、生涯を通じて男性の8人に1人、女性の16人に1人が発症しています。2000年には、結石症患者の管理とケアに20億米ドル近くが費やされ、そのコストは年々増加しています。米国南東部では、温暖な気候のために発汗量が増え、体液が失われ、尿量が減少するため、腎結石症が2倍多く見られます。

熟練した専門家の不足

世界の腎臓結石回収装置市場は、高度な検索技術の訓練を受けた熟練した専門家の不足という大きな課題に直面しています。開発途上地域や低開発地域では、泌尿器科医や専門のヘルスケアプロバイダーが不足しているため、尿管鏡検査、レーザー結石破砕術、ロボット支援介入などの高度な治療オプションの導入が制限されています。適切なトレーニングプログラムやワークショップがないことが、この問題をさらに悪化させています。ターゲットを絞ったトレーニングイニシアティブ、国際協力、医学教育への投資を通じてこのスキルギャップに対処することが、このギャップを埋め、市場浸透を改善するのに役立つと思われます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 腎臓結石症の罹患率の上昇
  • 抑制要因
    • 熟練した専門家の不足
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析

第6章 製品タイプ別

• 砕石器
• 尿管鏡
• 石除去バスケット
• 結石除去鉗子
• ステント

第7章 治療の種類別

• 体外衝撃波結石破砕術
• 経皮的腎結石破砕術
• 体内尿管鏡検査

第8章 エンドユーザー別

• 病院
• 外来手術センター（ASC）
• 専門クリニック

第9章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州地域
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 中東・アフリカ

第10章 競合情勢

• 競合シナリオ
• 市況・シェア分析
• M&A分析

第11章 企業プロファイル

• Boston Scientific Corporation
  • 会社概要
  • 製品ポートフォリオと概要
  • 財務概要
  • 主な発展
• Olympus Corporation
• Becton, Dickinson and Company
• Cook Medical
• Coloplast Group
• Dornier MedTech
• Storz Medical AG
• CR Bard Inc
• Stryker Corporation
• Karl Storz SE & Co. KG

第12章 付録

The global kidney stone retrieval devices market reached US$ 2.67 billion in 2023 and is expected to reach US$ 4.30 billion by 2033, growing at a CAGR of 4.8% during the forecast period 2025-2033.

Kidney stone disease, also known as nephrolithiasis, is a common urological condition involving mineral and salt crystals in the kidneys. Treatment involves specialized medical devices like ESWL, ureteroscopes, PCNL instruments, and advanced imaging systems. Technological advancements have led to the development of minimally invasive, highly effective devices that improve patient outcomes and reduce recovery times. The increasing prevalence of kidney stone disease and demand for non-invasive treatments continue to drive innovation in this medical device segment.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Kidney Stone Disease

The global kidney stone retrieval devices market is growing due to the increasing prevalence of kidney stone disease, which affects 10-15% of the global population. Factors like unhealthy diets, obesity, dehydration, and sedentary lifestyles contribute to the surge in kidney stone incidence. This has created a demand for effective, minimally invasive solutions like ureteroscopes, lithotripters, and stone retrieval baskets. The increasing awareness of early diagnosis and advanced treatment options has encouraged more patients to seek medical intervention, further boosting market growth. The demand for innovative, patient-centric retrieval devices is expected to grow exponentially, presenting significant opportunities for manufacturers and healthcare providers.

For instance, Kidney stone disease affects one in every 500 US individuals each year, with 1 in 8 men and 1 in 16 women developing the disease over their lifetime. In 2000, nearly $2 billion was spent on managing and caring for patients with stone disease, with the cost increasing annually. Nephrolithiasis is twice as common in the southeastern US due to warmer climates causing increased sweating, fluid loss, and lowered urine output.

Lack of Skilled Professionals

The global kidney stone retrieval devices market faces a significant challenge due to the lack of skilled professionals trained in advanced retrieval technologies. In developing and underdeveloped regions, the shortage of urologists and specialized healthcare providers limits the adoption of advanced treatment options like ureteroscopy, laser lithotripsy, and robotic-assisted interventions. The lack of adequate training programs and workshops further exacerbates the issue. Addressing this skill gap through targeted training initiatives, international collaborations, and investments in medical education could help bridge this gap and improve market penetration.

Segment Analysis

The global kidney stone retrieval devices market is segmented based on product type, treatment type, end user and region.

Product Type:

Lithotripters segment is expected to dominate the Kidney Stone Retrieval Devices market share

The lithotripters segment holds a major portion of the kidney stone retrieval devices market share and is expected to continue to hold a significant portion of the kidney stone retrieval devices market share during the forecast period.

Lithotripters are a crucial part of the global kidney stone retrieval devices market, used to treat kidney stones without invasive procedures. They use energy sources like shock waves, ultrasound, or lasers to break down kidney stones into smaller pieces, which can be naturally excreted or removed. Extracorporeal shock wave lithotripsy (ESWL) is popular due to its non-invasive nature and high success rates. Advanced laser lithotripters, like those used in ureteroscopy, offer precise stone fragmentation for complex or larger stones. Moreover, technological advancements, like AI for stone targeting and energy optimization, are expected to further enhance their market role.

For instance, in September 2024, according to a clinical trial in The Journal of Urology found that Break Wave lithotripsy (BWL) is a noninvasive ultrasound technology which offers a safe and effective treatment option for urinary stones,. The technology, which can be used in various settings without the need for anesthesia, has shown a high treatment success rate in its initial experience.

End User:

Hospitals segment is the fastest-growing segment in Kidney Stone Retrieval Devices market share

The hospitals segment is the fastest-growing segment in the kidney stone retrieval devices market share and is expected to hold the market share over the forecast period.

Hospitals are key players in the global kidney stone retrieval devices market, providing diagnosis, treatment, and post-operative care for patients with kidney stones. With advanced infrastructure and skilled medical professionals, they are preferred for complex surgical procedures like ureteroscopy, percutaneous nephrolithotomy, and ESWL. Hospitals offer a wide range of diagnostic imaging systems and treatment devices, including laser lithotripters and flexible ureteroscopes.

Moroever, they also conduct educational programs and training workshops to familiarize healthcare providers with the latest retrieval technologies. As kidney stone disease prevalence increases, hospitals expand their capacity to meet the growing patient load, boosting demand for kidney stone retrieval devices.

For instance, in October 2024, Osmania General Hospital in Hyderabad has acquired the first-of-its-kind Extracorporeal Shockwave Lithotripsy (ESWL) machine, providing a non-invasive solution for kidney stone removal. The machine was installed in the Urology Department under a Corporate Social Responsibility initiative by Mobis India Limited.

Geographical Analysis

North America is expected to hold a significant position in the Kidney Stone Retrieval Devices market share

North America holds a substantial position in the kidney stone retrieval devices market and is expected to hold most of the market share due to the increasing prevalence of kidney stones in the region, largely due to lifestyle factors such as poor diet, obesity, high salt intake, and a sedentary lifestyle. The aging population, particularly in the U.S. and Canada, is more prone to kidney-related issues, driving the demand for these devices. The North American healthcare system, with advanced infrastructure and high healthcare spending, supports the adoption of advanced kidney stone retrieval devices. High awareness about health and medical conditions drives the demand for minimally invasive and efficient treatments.

For instance, in November 2024, The FDA has granted de novo clearance to the Stone Clear device, which uses non-invasive ultrasound pulses to help patients pass residual kidney stone fragments post-lithotripsy. The device is designed to manage kidney stones in clinic settings without requiring anesthesia. The device is designed to reduce the burden of residual fragment stones in patients who are more likely to have complications, emergency department visits, or repeat procedures. The Stone Clear device provides patients with a reliable non-invasive option to reduce their burden while being fully awake.

Europe is growing at the fastest pace in the Kidney Stone Retrieval Devices market

Europe holds the fastest pace in the kidney stone retrieval devices market and is expected to hold most of the market share due to the aging population, increasing awareness of early detection and treatment, and the strong healthcare system. The region's rising healthcare expenditure and government initiatives also contribute to market growth. The focus on minimally invasive procedures and technological advancements in medical devices further drives the demand for these devices in Europe.

For instance, in June 2022, Hospital Clinic de Barcelona has introduced a new kidney stone surgery technique called Percutaneous Nephrolithotomy (PNL), which involves a percutaneous puncture in the lumbar region to access the inside of the kidney cavity. The procedure can lead to complications such as renal haemorrhage, renal haematoma infection, residual fragments, and urinoma, which are collections of extravasated urine from the urinary tract. The technique is coordinated by Dr. Juan Lopez, who is also the head of Urology Surgery.

Competitive Landscape

The major global players in the kidney stone retrieval devices market include Boston Scientific Corporation, Olympus Corporation, Becton, Dickinson and Company, Cook Medical, Coloplast Group, Dornier MedTech, Storz Medical AG, CR Bard Inc, Stryker Corporation, Karl Storz SE & Co. KG and among others.

Key Developments

• In November 2024, EndoTheia, Inc. has completed the first-in-human clinical trial for the FlexStone Basket, the first-ever independently steerable kidney stone basket. The device offers unparalleled precision and control in kidney stone removal, making it a significant advancement in urological care. The trial was conducted at Vanderbilt University Medical Center by Nicholas Kavoussi and Ryan Hsi.
• In August 2024, Calyxo, Inc., a medical device company, has released positive study results for its CVAC System in kidney stone clearance. The study found that healthcare consumption events, including emergency department visits, hospitalization, and retreatment, were significantly lower after steerable ureteroscopic renal evacuation (SURE) with the CVAC System compared to ureteroscopy (URS)

Emerging Players

The emerging players in the kidney stone retrieval devices market include Applaud Medical, Calyxo, Inc., Lumenis Ltd, DirexGroup, HealthTronics, Inc. and among others.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global kidney stone retrieval devices market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Treatment Type & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Treatment Type
• 3.3. Snippet by End User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Rising Prevalence of Kidney Stone Disease
  • 4.1.2. Restraints
    • 4.1.2.1. Lack of Skilled Professionals
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis

6. By Product Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 6.1.2. Market Attractiveness Index, By Product Type
• 6.2. Lithotripters*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Ureteroscopes
• 6.4. Stone Removal Baskets
• 6.5. Stone Removal Forceps
• 6.6. Stents

7. By Treatment Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
  • 7.1.2. Market Attractiveness Index, By Treatment Type
• 7.2. Extracorporeal Shock Wave Lithotripsy*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Percutaneous Nephrolithotripsy
• 7.4. Intracorporeal Ureteroscopy

8. By End User

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 8.1.2. Market Attractiveness Index, By End User
• 8.2. Hospitals*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Ambulatory Surgical Centers (ASCs)
• 8.4. Specialty Clinics

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
  • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.2.6.1. U.S.
    • 9.2.6.2. Canada
    • 9.2.6.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
  • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.3.6.1. Germany
    • 9.3.6.2. U.K.
    • 9.3.6.3. France
    • 9.3.6.4. Spain
    • 9.3.6.5. Italy
    • 9.3.6.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
  • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.4.6.1. Brazil
    • 9.4.6.2. Argentina
    • 9.4.6.3. Rest of South America
• 9.5. Asia-Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
  • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.5.6.1. China
    • 9.5.6.2. India
    • 9.5.6.3. Japan
    • 9.5.6.4. South Korea
    • 9.5.6.5. Rest of Asia-Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
  • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

• 11.1. Boston Scientific Corporation*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio and Description
  • 11.1.3. Financial Overview
  • 11.1.4. Key Developments
• 11.2. Olympus Corporation
• 11.3. Becton, Dickinson and Company
• 11.4. Cook Medical
• 11.5. Coloplast Group
• 11.6. Dornier MedTech
• 11.7. Storz Medical AG
• 11.8. CR Bard Inc
• 11.9. Stryker Corporation
• 11.10. Karl Storz SE & Co. KG

LIST NOT EXHAUSTIVE

12. Appendix

• 12.1 About Us and Services
• 12.2 Contact Us